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A corrigendum on
Clinical application of multigene panels: challenges of next-generation counseling and cancer
risk management
Slavin TP, Niell-Swiller M, Solomon I, Nehoray B, Rybak C, Blazer KR, et al. Front Oncol (2015) 5:208.
doi: 10.3389/fonc.2015.00208
On page 4 of our manuscript, line 528, there is an erroneous reference for Figure 3.
“Mosaic TP53
Case 2 is a 42-year-old unaffected woman of Northern European ancestry referred for interpretation
of ambiguous results from a breast focused multigene panel ordered by her referring physician due
to her maternal family history of cancer (Figure 3);”
Figure 3 only pertains to the CDH1 case above (correctly referenced there). Therefore, the
sentence should read:
“Case 2 is a 42-year-old unaffected woman ofNorthern European ancestry referred for interpreta-
tion of ambiguous results from a breast focused multigene panel ordered by her referring physician
due to her maternal family history of cancer;”
We apologize for any confusion this may have caused.
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